Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Roger Douglas Weiss, M.D.


This page shows the publications co-authored by Roger Weiss and Joji Suzuki.
Connection Strength

  1. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence? J Addict Med. 2021 04 01; 15(2):91-92.
    View in: PubMed
    Score: 0.929
  2. Medications for Opioid Use Disorder Demonstrate Clear Benefit for Patients With Invasive Infections: Letter-in-reply. J Addict Med. 2020 12; 14(6):518-519.
    View in: PubMed
    Score: 0.908
  3. Long-term Outcomes of Injection Drug-related Infective Endocarditis Among People Who Inject Drugs. J Addict Med. 2020 Jul/Aug; 14(4):282-286.
    View in: PubMed
    Score: 0.882
  4. Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis. Am J Addict. 2020 03; 29(2):155-159.
    View in: PubMed
    Score: 0.854
  5. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06.
    View in: PubMed
    Score: 0.596
  6. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68.
    View in: PubMed
    Score: 0.575
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.